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whereas nonparticipants presented more affective and anx-
iety disorders.  Conclusions: The results indicate that lower 
psychosocial functioning and comorbid affective and anxi-
ety disorders decrease BPD patients’ willingness to partici-
pate in an RCT.  Copyright © 2010 S. Karger AG, Basel
 Introduction
 In the last 15 years major randomized controlled trials 
(RCTs) on treatments for borderline personality disorder 
(BPD) have been published [e.g.  1–6 ]. These studies rare-
ly gave detailed information on their recruitment proce-
dures. As a consequence, there is little knowledge about 
patients who were eligible for the major RCTs but not 
willing to take part. Studying these patients is of special 
interest since it helps close the gap between RCT popula-
tions and clinical reality  [7] .
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 Abstract
 Background: Despite the notion that randomized con-
trolled trials are regarded as the gold standard in psycho-
therapy research, questions about their generalizability 
have been raised. This paper focuses on the differences be-
tween participants and eligible nonparticipants of a ran-
domized controlled trial for patients with borderline person-
ality disorder (BPD).  Sampling and Methods: One hundred 
forty-two patients were screened, and 122 were found eli-
gible for study participation. Out of these, 64 patients (52.5%) 
gave informed consent and were included in the study.  Re-
sults: The 58 eligible nonparticipants showed a lower level 
of functioning (global assessment of functioning score), had 
a history of more outpatient treatment attempts and were 
living alone more often. Regarding acute symptoms and
severity of BPD as indexed by suicide attempts, inpatient 
treatments, substance abuse and history of trauma, no dif-
ferences between the groups could be detected. Moreover, 
participants showed significantly more eating disorders, 
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 This paper investigates the differences between par-
ticipants and eligible nonparticipants of an RCT for the 
treatment of BPD and the factors that influence a pa-
tient’s willingness to participate in the RCT. Based on 
our clinical experience and the very scarce pool of litera-
ture on this topic [e.g.  8 ], we tested the hypothesis that 
the group of patients who denied participation in the 
study showed significantly more pathology than the par-
ticipants. 
 Method
 Background
 This study was performed as part of a German/Austrian mul-
ticenter RCT  [9] comparing the effectiveness of transference-fo-
cused psychotherapy  [10] to treatment delivered by experienced 
community psychotherapists for individuals with BPD. The in-
clusion and exclusion criteria are summarized in  table 1 . 
 Procedure
 The study was approved by the local ethics committee. The 
study recruitment took place at the Outpatient Department of a 
German University Psychiatric Hospital from October 2004 to 
July 2006. Most patients came on their own initiative or on refer-
ral from psychiatric treatment settings (e.g. crisis intervention 
units, psychiatric hospitals, private practices). During the initial 
psychiatric interview, the patients were informed about the study 
procedures and details as well as alternatives to study participa-
tion. A notion of preference for 1 of the 2 treatment approaches 
was strictly avoided. Additionally, the initial psychiatric inter-
view was designed as a clinical screening instrument for study 
inclusion and exclusion criteria. The interviews lasted about 60 
min, and all study interviews were performed by the same psy-
chiatrist (M.R.). Axis I disorders were clinically diagnosed ac-
cording to DSM-IV criteria and the global assessment of func-
tioning score (GAF;  [11] ) was recorded. Regarding axis II disor-
ders, the patients received diagnoses based on clinical judgment, 
focusing on BPD and antisocial personality disorder exclusively. 
The patients were additionally asked about psychiatric disorders 
of parents and relatives. Their history of traumatic events was ex-
plored in a nonstandardized format. For this, the interviewer typ-
ically explored the nature of the trauma and the age at which it 
occurred. The nature of the trauma was coded as (a) sexual, (b) 
physical and (c) emotional, and for quantitative analyses, multiple 
traumatizations were assigned to the category corresponding to 
the severest trauma (a  1 b  1 c). Demographic information was 
obtained from the routine documentation in the patient charts.
 Data Analysis
 The statistical analyses were carried out with SPSS for Win-
dows (version 14.0). Group differences on continuous data were 
examined by 2-sided t tests. All variables were tested with regard 
to normal distribution (Kolmogorov-Smirnov test; p  ! 0.05). For 
nonnormally distributed variables, the results were confirmed 
with Kruskal-Wallis H tests. Group differences on categorical 
data were examined with   2  tests. 
 Results
 One hundred forty-two patients were screened. Out of 
these, study participation was offered to 122 female pa-
tients with a clinical diagnosis of BPD. Eleven patients 
showed exclusion criteria: 2 were male, 8 were diagnosed 
as having present alcohol or substance addiction, and 1 
patient suffered from schizophrenia. Moreover, 9 patients 
did not fulfill the diagnostic criteria of BPD according to 
DSM-IV.
 Sixty-four patients (52.5%) agreed to participate, and 
58 (47.5%) rejected the offer to take part in the study. Af-
ter completing the assessment procedure, none of the 64 
participants had to be rejected due to clinically undetect-
ed exclusion criteria. Among the 58 nonparticipants, 20 
patients (34.5%) were interested in a specific treatment, 
e.g. DBT, which was not offered in the study protocol. Six 
patients (10.3%) did not want to give up the therapist 
treating them before study enrollment. Three individuals 
(5.2%) did not agree to be randomized, 5 patients (8.6%) 
were searching for inpatient treatment due to a crisis situ-
ation, and 24 individuals (41.4%) stopped contacting the 
research team for unknown reasons.
 Group differences with regard to symptom severity, 
comorbidity, trauma history and family history are dis-
played in  table 2 .
 Nonparticipants yielded a significantly lower GAF 
score in the assessment. Only 1 patient with a GAF score 
 ! 40 was willing to participate, whereas 16 patients in the 
group of nonparticipants were assigned a GAF score  ! 40. 
In terms of demographic variables, only the patients’ liv-
ing situation was different; nonparticipants were more 
likely to live alone (p  ! 0.01). With respect to education 
and employment situation, there was a trend below the 
level of statistical significance: participants showed a 
 Table 1. I nclusion and exclusion criteria
 Inclusion criteria 
 Female gender
 Age between 18 and 45 years
 BPD according to DSM IV
 Sufficient knowledge of the German language 
 Exclusion criteria 
 Lifetime diagnosis of schizophrenia
 Present major affective disorder
 Present substance dependency
 Obvious mental retardation 
 Antisocial personality disorder 
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slightly higher level of education (higher level of school 
degree 32.8 vs. 22.4%,   2  = 7.31, p = 0.19) and were work-
ing full time more frequently (work full time 31.2 vs. 
12.1%,   2  = 11.92, p = 0.06).
 Discussion
 This paper explores the differences between study par-
ticipants and nonparticipants in an RCT for BPD pa-
tients. Two major findings emerge from this study. The 
first one is that borderline patients who did not partici-
pate in the RCT did not differ from participants in acute 
symptoms and severity of BPD nor in factors often re-
garded relevant to the etiology of BPD (e.g. suicide at-
tempts, substance abuse, history of trauma, parents’ and 
relatives’ psychiatric disorders, as well as educational and 
occupational situation). The second finding is that non-
participants were different from patients who chose to 
participate in variables of general functioning and co-
morbidity. Eligible nonparticipants showed worse psy-
chosocial functioning and a higher number of previous 
outpatient psychotherapies, and tended to live alone more 
frequently than participants. They also showed different 
comorbid axis I disorders, with nonparticipants present-
ing pathology in the areas of affective and anxiety disor-
ders, whereas participants more frequently suffered from 
eating disorders. We conclude that especially patients 
with a GAF score  ! 40 may be at the limit of outpatient 
treatability and can be considered as a group of individu-
als more often in need of hospitalization, perhaps with 
subsequent outpatient treatment. 
 The group of patients who finally participate in an 
RCT is determined by several steps in the patient flow. 
First, inclusion and exclusion criteria filter out a group of 
patients and then, the patients’ willingness to participate 
yields the final sample. The external validity of a study 
can be limited by rigid inclusion and exclusion criteria, 
which in turn makes inclusion unlikely for a vast major-
ity of the ordinary clinical population  [12–14] . With a 
proportion of 86% (122 of 142) of all screened patients 
found eligible for study participation, our enrolment pro-
tocol seems to be acceptably close to ‘real-life’ conditions. 
This is remarkably higher than the ratio reported by Clar-
kin et al.  [4] in a study with a similar design. In this study 
207 patients were screened and only 109 were offered 
study participation, resulting in a ratio of 52.7%  [15] . 
 Still there are some serious limitations to the approach 
presented in this paper. First, the diagnosis of the group 
of nonparticipants is based on a clinical interview only. 
This makes the assumed diagnosis of a BPD likely but not 
confirmed by standardized instruments. While planning 
this study we found it difficult to implement a more com-
plicated design due to the fact that the vast majority of 
nonparticipants was not willing to undergo any scien-
tific protocol, making it nearly impossible to collect as-
 Table 2. C omparison between nonparticipants and participants
 Nonparticipants
 (n = 58) 
 Participants
 (n = 64) 
  2 p value 
 GAF  42.4 8 7.2  52.4 8 6.8  <0.001 
 Outpatient psychotherapies 1.9 8 2.3 1.2 8 1.2  <0.05 
 Psychiatric inpatient treatments 3.2 8 3.7 2.4 8 2.5 n.s. 
 Suicide attempts 1.4 8 3.3 1.4 8 2.1 n.s. 
 Age, years  30.4 8 9.4  28.9 8 7.1 n.s. 
 Age at first diagnosis of psychiatric symptoms, years  19.6 8 7.2  19.2 8 7.2 n.s. 
 Age at diagnosis of BPD  25.4 8 8.2  25.7 8 6.9 n.s. 
 Present comorbidity 26 (43) 26 (41) n.s. 
 Major depressive disorder 6 (10) 1 (2)  11.93 (d.f. = 4)  <0.5 
 Eating disorders 13 (22) 23 (36)  10.20 (d.f. = 7)  <0.5 
 Present and lifetime diagnosis of substance abuse 31 (53) 35 (55) n.s. 
 History of trauma (sexual, physical, emotional) 36 (62) 40 (63) 2.24 (d.f. = 3) n.s. 
 Psychiatric disorders in relatives 
 Parents
 Grandparent, uncle/aunt, sibling 
24 (41)
12 (21) 
31 (48)
20 (31) 
3.36 (d.f. = 5)
4.55 (d.f. = 5) 
n.s.
n.s. 
 R esults are expressed as means  8 SD or numbers with percentages in parentheses. 
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sured data on this special subgroup of patients. Second, 
the part of patients, who – after the first interview – nev-
er contacted the research team again (24 individuals) is 
rather high, which might reflect that study participation 
was ‘not attractive to patients’. It may well be due to the 
fact that the German health care system provides quite 
some comfort to patients seeking psychotherapy. Besides 
taking over the therapist fees, health insurance concedes 
the chance to meet several therapists in up to 5 sessions 
on a probationary basis. To our knowledge, many of the 
potential study participants were in this process of find-
ing the therapist who really ‘fits’ and study participation 
was just one possibility of finding treatment among many. 
There may also be other aspects in terms of requirements 
to participate in our study that might have deterred pa-
tients from participation. 
 Further research should study eligible nonparticipants 
as well as dropouts in detail in order to help identify so-
called endophenotypes of BPD  [16] as a basis for the de-
velopment of more syndrome-tailored treatment ap-
proaches.
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